Ascribe Bioscience
Latest round
- Series A
Last raised
- Oct 2025
Total raised
- $18M
Investors
- 8
About Ascribe Bioscience
Founded in 2017 and based in New York, US, Ascribe Bioscience operates as a developer of natural crop protection based on small molecules in the soil microbiome that helps to protect their products without destroying the environment.
Who invested in Ascribe Bioscience
8 investors across 2 rounds
See all investors in Ascribe Bioscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ascribe Bioscience
Who invested in Ascribe Bioscience?
Ascribe Bioscience has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ascribe Bioscience raised?
Ascribe Bioscience has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Ascribe Bioscience last raise money?
Ascribe Bioscience's most recent round on record is a Series A, in Oct 2025.
What does Ascribe Bioscience do?
Founded in 2017 and based in New York, US, Ascribe Bioscience operates as a developer of natural crop protection based on small molecules in the soil microbiome that helps to protect their products without destroying the environment.
Where is Ascribe Bioscience headquartered?
Ascribe Bioscience is headquartered in Ithaca, US.
Which VCs invest in companies like Ascribe Bioscience?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back agribusiness companies at Ascribe Bioscience's stage. Their profiles are linked below.
VCs backing agribusiness startups at Series A
Raising like Ascribe Bioscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.